AIMS: The aim of this study was to explore the association between pedometer-determined physical activity versus measures of obesity, inflammatory markers and arterial stiffness in people with Type 2 diabetes. METHODS: We analysed data from 224 men and 103 women with Type 2 diabetes, aged 54-66 years. Physical activity was measured with waist-mounted pedometers during three consecutive days and the number of steps/day were calculated and classified in four groups: < 5000 steps/day, 5000-7499 steps/day, 7500-9999 steps/day and ≥ 10000 steps/day. Blood samples were analysed for lipids, HbA(1c), inflammatory markers including C-reactive protein and interleukin-6. Nurses measured blood pressure and anthropometrics. Aortic pulse wave velocity was measured with applanation tonometry over the carotid and femoral arteries. RESULTS: Mean steps/day was 7683 ± 3883 (median 7222, interquartile range 4869-10,343). There were no differences in age, diabetes duration, blood pressure, lipids or glycaemic control between the four groups of pedometer-determined physical activity. Subjects with higher steps/day had lower BMI (28.8 vs. 31.5 kg/m(2), P < 0.001), waist circumference (101.7 vs. 108.0 cm, P < 0.001), lower levels of C-reactive protein (1.6 vs. 2.6 mg/l, P = 0.007), lower levels of interleukin-6 (1.9 vs. 3.8 pg ml, P < 0.001) and lower pulse wave velocity (10.2 vs. 11.0 m/s, P = 0.009) compared with less physically active people. CONCLUSIONS: We conclude that physical activity measured with pedometer was associated not only with less abdominal obesity, but also with decreased systemic low-grade inflammation as well as with low arterial stiffness, in people with Type 2 diabetes.
AIMS: The aim of this study was to explore the association between pedometer-determined physical activity versus measures of obesity, inflammatory markers and arterial stiffness in people with Type 2 diabetes. METHODS: We analysed data from 224 men and 103 women with Type 2 diabetes, aged 54-66 years. Physical activity was measured with waist-mounted pedometers during three consecutive days and the number of steps/day were calculated and classified in four groups: < 5000 steps/day, 5000-7499 steps/day, 7500-9999 steps/day and ≥ 10000 steps/day. Blood samples were analysed for lipids, HbA(1c), inflammatory markers including C-reactive protein and interleukin-6. Nurses measured blood pressure and anthropometrics. Aortic pulse wave velocity was measured with applanation tonometry over the carotid and femoral arteries. RESULTS: Mean steps/day was 7683 ± 3883 (median 7222, interquartile range 4869-10,343). There were no differences in age, diabetes duration, blood pressure, lipids or glycaemic control between the four groups of pedometer-determined physical activity. Subjects with higher steps/day had lower BMI (28.8 vs. 31.5 kg/m(2), P < 0.001), waist circumference (101.7 vs. 108.0 cm, P < 0.001), lower levels of C-reactive protein (1.6 vs. 2.6 mg/l, P = 0.007), lower levels of interleukin-6 (1.9 vs. 3.8 pg ml, P < 0.001) and lower pulse wave velocity (10.2 vs. 11.0 m/s, P = 0.009) compared with less physically active people. CONCLUSIONS: We conclude that physical activity measured with pedometer was associated not only with less abdominal obesity, but also with decreased systemic low-grade inflammation as well as with low arterial stiffness, in people with Type 2 diabetes.
Authors: Rodney P Joseph; Barbara E Ainsworth; Sonia Vega-López; Marc A Adams; Kevin Hollingshead; Steven P Hooker; Michael Todd; Glenn A Gaesser; Colleen Keller Journal: Contemp Clin Trials Date: 2018-12-18 Impact factor: 2.226
Authors: Margareta Ring; Maria J Eriksson; Tomas Fritz; Gunnar Nyberg; Claes Göran Östenson; Anna Krook; Juleen R Zierath; Kenneth Caidahl Journal: Diab Vasc Dis Res Date: 2015-06-19 Impact factor: 3.291
Authors: Pär Jennersjö; Hans Guldbrand; Stefan Björne; Toste Länne; Mats Fredrikson; Torbjörn Lindström; Magnus Wijkman; Carl Johan Östgren; Fredrik H Nystrom Journal: Diabetol Metab Syndr Date: 2015-06-12 Impact factor: 3.320
Authors: Charlotte Andersson; Asya Lyass; Martin G Larson; Nicole L Spartano; Joseph A Vita; Emelia J Benjamin; Joanne M Murabito; Dale W Esliger; Susan J Blease; Naomi M Hamburg; Gary F Mitchell; Ramachandran S Vasan Journal: J Am Heart Assoc Date: 2015-03-19 Impact factor: 5.501
Authors: Mark Hamer; Ruth A Hackett; Sophie Bostock; Antonio I Lazzarino; Livia A Carvalho; Andrew Steptoe Journal: BMJ Open Diabetes Res Care Date: 2014-06-13
Authors: Rachel E D Climie; Chris Moran; Michele Callisaya; Leigh Blizzard; James E Sharman; Alison Venn; Thanh G Phan; Richard Beare; Josephine Forbes; Nicholas B Blackburn; Velandai Srikanth Journal: PLoS One Date: 2015-11-11 Impact factor: 3.240